Loading
Built the data centre behind the Japan Clinical Oncology Group, the country's main academic trials network.
Haruhiko Fukuda is the founding director of the JCOG Data Center at the National Cancer Center in Tokyo and a clinical trial methodologist. He established and long led the data centre behind the Japan Clinical Oncology Group, the country's main academic trials network, setting the methodological standards for its cooperative-group surgical, radiotherapy and chemotherapy trials in gastric, oesophageal, lung and other cancers. His publications include the JCOG0802 trial of segmentectomy against lobectomy in small peripheral non-small-cell lung cancer, the JCOG1013 trial of docetaxel added to cisplatin and S-1 in advanced gastric cancer, and the JCOG0603 trial of hepatectomy followed by mFOLFOX6 in liver-only metastatic colorectal cancer. His interests are trial methodology and biostatistics.
Shares Japan Clinical Oncology Group (JCOG), National Cancer Center Hospital, Oesophageal cancer, Gastric & gastro-oesophageal junction cancer.
Shares National Cancer Center Hospital, Oesophageal cancer, Gastric & gastro-oesophageal junction cancer.
Shares Japan Clinical Oncology Group (JCOG), Oesophageal cancer, Gastric & gastro-oesophageal junction cancer, Non-small-cell lung cancer.
Shares Japan Clinical Oncology Group (JCOG), National Cancer Center Hospital, Oesophageal cancer, Gastric & gastro-oesophageal junction cancer.
Shares Japan Clinical Oncology Group (JCOG), National Cancer Center Hospital, Gastric & gastro-oesophageal junction cancer, Non-small-cell lung cancer.
Shares National Cancer Center Hospital, Non-small-cell lung cancer.
Shares Japan Clinical Oncology Group (JCOG), Oesophageal cancer, Gastric & gastro-oesophageal junction cancer, Non-small-cell lung cancer.
Shares Japan Clinical Oncology Group (JCOG), Oesophageal cancer.